D. Herrero Rivera

Also affiliated with Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Hospital Universitario HM Madrid, Molecular Oncology (United States), Hospital Universitario Virgen del Rocío, Universidad Europea de Madrid

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Development and Independent Validation of a Prognostic Gene Expression Signature Based on RB1, PTEN, and TP53 in Metastatic Hormone-sensitive Prostate Cancer Patients”.

Development and Independent Validation of a Prognostic Gene Expression Signature Based on RB1, PTEN, and TP53 in Metastatic Hormone-sensitive Prostate Cancer Patients

European Urology Oncology(2024)10.1016/j.euo.2023.12.012

N/A

0.396DataRank · unranked

13 citations

Marta García de Herreros, Òscar Reig, Mercedes Marín‐Aguilera, Caterina Aversa, Laura Ferrer‐Mileo +21 more